Tabula Rasa HealthCare, Inc. (TRHC): Price and Financial Metrics
GET POWR RATINGS... FREE!
TRHC POWR Grades
- TRHC scores best on the Growth dimension, with a Growth rank ahead of 80.14% of US stocks.
- The strongest trend for TRHC is in Momentum, which has been heading down over the past 31 weeks.
- TRHC's current lowest rank is in the Quality metric (where it is better than 3.99% of US stocks).
TRHC Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for TRHC is 3.6 -- better than 87.65% of US stocks.
- Price to trailing twelve month operating cash flow for TRHC is currently 694.87, higher than 99.43% of US stocks with positive operating cash flow.
- Over the past twelve months, TRHC has reported earnings growth of 105.7%, putting it ahead of 84.71% of US stocks in our set.
- Stocks that are quantitatively similar to TRHC, based on their financial statements, market capitalization, and price volatility, are UPLD, HCAT, FEYE, ONEM, and NEWR.
- TRHC's SEC filings can be seen here. And to visit Tabula Rasa HealthCare Inc's official web site, go to www.tabularasahealthcare.com.
TRHC Valuation Summary
- TRHC's price/earnings ratio is -13; this is 132.99% lower than that of the median Technology stock.
- Over the past 58 months, TRHC's price/earnings ratio has gone up 5.
- Over the past 58 months, TRHC's EV/EBIT ratio has gone down 100.6.
Below are key valuation metrics over time for TRHC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| TRHC | 2021-04-12 | 3.6 | 6.4 | -13.3 | -20.3 |
| TRHC | 2021-04-05 | 3.9 | 6.9 | -14.3 | -21.5 |
| TRHC | 2018-12-18 | 6.7 | 13.1 | -49.7 | -41.7 |
| TRHC | 2017-06-09 | 2.6 | 4.5 | -180.0 | 201.7 |
| TRHC | 2017-04-12 | 2.4 | 4.1 | -166.6 | 185.6 |
| TRHC | 2016-12-13 | 3.1 | -7.4 | -16.7 | 76.6 |
TRHC Price Target
For more insight on analysts targets of TRHC, see our TRHC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $50.99 | Average Broker Recommendation | 1.68 (Moderate Buy) |
TRHC Stock Price Chart Interactive Chart >
TRHC Price/Volume Stats
| Current price | $40.73 | 52-week high | $69.31 |
| Prev. close | $41.28 | 52-week low | $30.12 |
| Day low | $39.74 | Volume | 331,000 |
| Day high | $41.16 | Avg. volume | 316,877 |
| 50-day MA | $45.47 | Dividend yield | N/A |
| 200-day MA | $43.66 | Market Cap | 1.01B |
Tabula Rasa HealthCare, Inc. (TRHC) Company Bio
Tabula Rasa HealthCare, Inc. provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to enhance patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. The company was founded in 2009 and is based in Moorestown, New Jersey.
Latest TRHC News From Around the Web
Below are the latest news stories about Tabula Rasa HealthCare Inc that investors may wish to consider to help them evaluate TRHC as an investment opportunity.
Tabula Rasa HealthCare Schedules Second Quarter 2021 Earnings Conference CallTabula Rasa HealthCare, Inc. (NASDAQ: TRHC), will hold a conference call and webcast to discuss its second quarter 2021 operating results Friday, August 6, 2021 at 8:30 a.m. EDT. The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder and President, Orsula V. Knowlton, PharmD, MBA; and TRHC Chief Financial Officer, Brian W. Adams. The Company's financial results for the second quarter 2021 ending June 30, 2021, will be released after the c |
Tabula Rasa HealthCare Announces Key Additions to its Leadership TeamMOORESTOWN, N.J., July 6, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announces the addition of two proven healthcare executives to fill strategic positions as TRHC prepares |
Tabula Rasa HealthCare Inks Agreements with 12 State Pharmacy Associations to Bring MedWise® Medication Risk Mitigation to MembersMOORESTOWN, N.J., June 29, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, is collaborating with four more state pharmacy associations to bring TRHC''s MedWise® technology to association |
RBC Capital Stick to Their Buy Rating for Tabula Rasa HealthCare By Investing.comRBC Capital Stick to Their Buy Rating for Tabula Rasa HealthCare |
Tabula Rasa HealthCare Enhances PrescribeWellness Software with MedWise Risk LevelMOORESTOWN, N.J., June 16, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that its new MedWise Risk Level, is now available directly through the PrescribeWellness |
TRHC Price Returns
| 1-mo | -20.45% |
| 3-mo | -12.77% |
| 6-mo | -28.28% |
| 1-year | -26.53% |
| 3-year | -32.89% |
| 5-year | N/A |
| YTD | -4.93% |
| 2020 | -12.00% |
| 2019 | -23.65% |
| 2018 | 127.31% |
| 2017 | 87.25% |
| 2016 | N/A |
Continue Researching TRHC
Want to see what other sources are saying about Tabula Rasa HealthCare Inc's financials and stock price? Try the links below:Tabula Rasa HealthCare Inc (TRHC) Stock Price | Nasdaq
Tabula Rasa HealthCare Inc (TRHC) Stock Quote, History and News - Yahoo Finance
Tabula Rasa HealthCare Inc (TRHC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...